Abstract
IL-34 is a recently discovered cytokine that acts on tissue resident macrophages and Langerhans cells upon binding the receptor for CSF-1, CSF-1R. The existence of two ligands for CSF-1R, IL-34, and CSF-1, raises several intriguing questions. Are IL-34 and CSF-1 redundant or does each perform temporally and spatially distinct functions? Is IL-34 involved in human pathology? Would therapeutic strategies based on selective inhibition or administration of either IL-34 or CSF-1 be advantageous for preventing human pathology? Recent in vivo studies indicate that IL-34 promotes the development, survival, and function of microglia and Langerhans cells; therefore, this cytokine may predominately function in brain and skin biology. Here, we review the evidence for IL-34 as a key cytokine in the development and function of these two diverse cell types and discuss its potential role in pathological conditions.
Original language | English |
---|---|
Pages (from-to) | 1575-1581 |
Number of pages | 7 |
Journal | European Journal of Immunology |
Volume | 44 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2014 |
Keywords
- CSF-1
- IL-34
- Langerhans cell
- M-CSF
- Macrophage
- Microglia
- Osteoclast